You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

12-008

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obese Trial in Timisoara (Glucose 8 g coated beads (47% w/w), Glucose 12 g coated beads (47% w/w), Glucose 16 g coated beads

Completed
  • Obese
  • Glucose 8 g coated beads (47% w/w)
  • +4 more
  • Timisoara, Romania
    NovaClin Medical Research Center S.R.L
Feb 17, 2023

Advanced Pancreatic Cancer Trial in Worldwide (Cabiralizumab, Nab-paclitaxel, Onivyde)

Active, not recruiting
  • Advanced Pancreatic Cancer
  • Cabiralizumab
  • +8 more
  • Phoenix, Arizona
  • +40 more
Apr 6, 2022

Solid Tumor, Adult Trial in Xi'an (Bio-008)

Recruiting
  • Solid Tumor, Adult
  • Bio-008
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of the Chinese People's Liberation
Aug 30, 2023

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Small Cell Lung Carcinoma Trial in Worldwide (Pembrolizumab/Vibostolimab Co-Formulation, Saline , Etoposide)

Recruiting
  • Small Cell Lung Carcinoma
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +5 more
  • Los Angeles, California
  • +122 more
Jan 27, 2023

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • ATG-010 and ATG-008
  • Chongqing, Chongqing, China
  • +5 more
Sep 2, 2022

Crohn's Disease, IBD Trial in Worldwide (Brazikumab Induction Dose, Brazikumab Maintenance Dose)

Enrolling by invitation
  • Crohn's Disease
  • IBD
  • Brazikumab Induction Dose
  • Brazikumab Maintenance Dose
  • Lincoln, California
  • +116 more
Jan 12, 2023

Metastatic NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Docetaxel)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Bakersfield, California
  • +142 more
Sep 1, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +31 more
Nov 11, 2021

Type 2 Diabetes Trial in Nanjing (SY-008, SY-008 matching )

Completed
  • Type 2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing Gulou Hospital
May 17, 2022

Pain Trial in Pasadena (CA-008, Ketorolac, Acetaminophen IV)

Completed
Has Results
  • Pain
  • Pasadena, California
    Lotus Clinical Research, LLC
Sep 29, 2021

Postsurgical Pain Trial in United States (CA-008, Placebo)

Completed
Has Results
  • Postsurgical Pain
  • Pasadena, California
  • +3 more
Dec 17, 2021

Postsurgical Pain Trial in Houston (CA-008, Placebo)

Completed
Has Results
  • Postsurgical Pain
  • Houston, Texas
    HD Research
Jan 25, 2022

Postsurgical Pain Trial in Pasadena (CA-008 5 mg, Placebo, Bupivacaine Hydrochloride)

Completed
Has Results
  • Postsurgical Pain
  • CA-008 5 mg
  • +8 more
  • Pasadena, California
    Lotus Clinical Research, LLC
Jan 4, 2022

Ulcerative Colitis Trial in Worldwide (Brazikumab Maintenance Dose, Brazikumab Induction Dose)

Enrolling by invitation
  • Ulcerative Colitis
  • Brazikumab Maintenance Dose
  • Brazikumab Induction Dose
  • Chula Vista, California
  • +138 more
Mar 16, 2022

Pneumococcal Infection Trial (V116, Placebo for PCV15 + PPSV23, PCV15)

Not yet recruiting
  • Pneumococcal Infection
  • V116
  • +3 more
  • (no location specified)
Jan 13, 2023

Respiratory Syncytial Virus Infections Trial in Baltimore (D46cp?M2-2 vaccine, Placebo)

Completed
  • Respiratory Syncytial Virus Infections
  • D46cpΔM2-2 vaccine
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Mar 26, 2020

Carcinoma, Squamous Cell, Non-small-cell Lung Trial in Worldwide (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Carcinoma, Squamous Cell, Non-small-cell Lung
  • Pembrolizumab
  • +5 more
  • Birmingham, Alabama
  • +177 more
Aug 22, 2022

Healthy Volunteer, Dry Age-related Macular Degeneration Trial (Tinlarebant (LBS-008))

Not yet recruiting
  • Healthy Volunteer
  • Dry Age-related Macular Degeneration
  • Tinlarebant (LBS-008)
  • (no location specified)
Dec 19, 2022

Dermatitis, Atopic Trial in Alken (MK-6194, Placebo)

Recruiting
  • Dermatitis, Atopic
  • MK-6194
  • Placebo
  • North Little Rock, Arkansas
  • +9 more
Jan 18, 2023

Alzheimer's Disease Trial in Canada, Korea, Republic of, United States (MK-1942, Placebo)

Recruiting
  • Alzheimer's Disease
  • Atlantis, Florida
  • +14 more
Jan 19, 2023

End-Stage Renal Disease, Kidney Failure, Chronic Trial in Tampa, Jerusalem, Bucure?ti (MK-2060)

Active, not recruiting
  • End-Stage Renal Disease
  • Kidney Failure, Chronic
  • Tampa, Florida
  • +2 more
Oct 26, 2022

Schizophrenia Trial in Worldwide (MK-8189, Risperidone, Placebo to MK-8189)

Recruiting
  • Schizophrenia
  • Bentonville, Arkansas
  • +92 more
Jan 5, 2023

Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer Trial in Marseille (IPH5301 ALONE OR IN COMBINATION

Recruiting
  • Metastatic Cancer
  • +8 more
  • IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
  • Marseille, France
    Institut Paoli Calmettes
Feb 23, 2022

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer Trial in Chongqing (ATG-008,

Not yet recruiting
  • 1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer
  • Chongqing, Chongqing, China
    Chongqing Cancer Hospital
Aug 4, 2021